Venous Thromboembolism Prophylaxis
This measure assesses the number of patients who received venous thromboembolism (VTE) prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. This measure is part of a set of six nationally implemented prevention and treatment measures that address VTE (VTE-2: ICU VTE Prophylaxis, VTE-3: VTE Patients with Anticoagulation Overlap Therapy, VTE-4: VTE Patients Receiving UFH with Dosages/Platelet Count Monitoring, VTE-5: VTE Warfarin Therapy Discharge Instructions and VTE-6: Hospital Acquired Potentially-Preventable VTE) that are used in The Joint Commission’s accreditation process.
ACP does not support NQF measure #0371: “Venous Thromboembolism Prophylaxis.” This measure represents an important clinical concept; however, the latest performance data from 2010 approaches a 90% performance rate and by now, this measure is likely topped out. Additionally, the specifications are flawed. The specifications should include exclusion criteria for patients who already receive full-dose anticoagulation therapy. Furthermore, it is unclear why exclusion criteria include patients with mental disorders. Lastly, developers should revise the exclusion criteria to include “hemorrhagic” stroke.